A newly discovered ocean bacteria called Lactiplantibacillus plantarum EI6 produces GABA, a brain-calming chemical, at levels of 0.96 grams per liter and contains multiple genes supporting gut health and immune function. According to Gram Research analysis, genetic testing revealed no dangerous virulence or antibiotic resistance factors, positioning this marine strain as a potentially safe psychobiotic candidate for future functional foods and supplements designed to support mental wellness through the gut-brain connection.
Scientists discovered a special type of bacteria from the ocean that produces a brain-boosting chemical called GABA. According to Gram Research analysis, this marine bacteria strain, called Lactiplantibacillus plantarum EI6, appears to have multiple health benefits including supporting gut health, reducing stress, and protecting against harmful substances. The bacteria produces GABA at levels of 0.96 grams per liter and contains genes that help it survive stomach acid and bile. Researchers found no dangerous virulence factors or antibiotic resistance genes, suggesting it could be safe for use in functional foods and supplements designed to support mental health and digestive wellness.
Key Statistics
A 2026 genomic analysis of the marine strain Lactiplantibacillus plantarum EI6 found that the bacteria produces GABA at a concentration of 0.96 grams per liter and contains genes for acid tolerance, bile resistance, and antioxidant activity, with no detected virulence factors or antibiotic resistance genes.
The complete genome of Lactiplantibacillus plantarum EI6 spans 3.3 million base pairs with a 44.5% GC composition and encodes multiple probiotic-associated genes including the gadB system responsible for GABA production, according to 2026 research in the World Journal of Microbiology and Biotechnology.
Genetic analysis of the marine probiotic candidate Lactiplantibacillus plantarum EI6 identified putative bacteriocin gene clusters and secondary metabolite biosynthetic gene clusters for terpenes and other compounds, supporting its potential as a multifunctional psychobiotic strain.
The Quick Take
- What they studied: Whether a newly discovered ocean-dwelling bacteria could be a safe and effective probiotic that produces GABA, a chemical that helps calm the brain and support mental health.
- Who participated: This was a laboratory study analyzing the complete genetic makeup of a single marine bacterial strain (Lactiplantibacillus plantarum EI6). No human participants were involved in this genomic analysis.
- Key finding: The bacteria successfully produces GABA at a level of 0.96 grams per liter and contains multiple genes supporting probiotic functions like surviving stomach acid, sticking to gut walls, and reducing inflammation, with no dangerous safety concerns detected.
- What it means for you: This research suggests a potential new probiotic option that could support both gut and brain health, though human studies are still needed to confirm benefits. It appears safe based on genetic analysis, but real-world testing in people would be required before it becomes available as a supplement.
The Research Details
Scientists performed a complete genetic analysis of a marine bacteria strain collected from ocean environments. They sequenced and studied the entire 3.3 million base pair genome (the complete genetic instruction manual) of the bacteria to identify all genes and their functions. The researchers used laboratory techniques called TLC and HPLC to measure exactly how much GABA the bacteria could produce under controlled conditions. They also searched the genome for genes related to probiotic benefits, safety concerns, and the ability to produce other beneficial compounds. This type of research is called genomic characterization, meaning they mapped out all the genetic information to understand what the bacteria can do.
Understanding a bacteria’s complete genetic blueprint allows scientists to predict its benefits and safety before testing it in humans. By identifying specific genes responsible for GABA production and probiotic functions, researchers can confidently recommend candidates for further development. This approach is much faster and safer than traditional testing methods because it reveals potential problems upfront, like antibiotic resistance genes or virulence factors that could cause harm.
This study provides solid foundational science through complete genome sequencing, a gold-standard technique for understanding bacterial genetics. The researchers confirmed GABA production using two independent laboratory methods (TLC and HPLC), which strengthens confidence in the results. However, this is laboratory research only, not human studies, so the actual health benefits remain theoretical until tested in people. The study was published in a peer-reviewed scientific journal, meaning other experts reviewed it for accuracy.
What the Results Show
The marine bacteria strain Lactiplantibacillus plantarum EI6 has a genome of 3.3 million base pairs with a genetic composition of 44.5% GC (guanine-cytosine content). The bacteria contains the gadB gene system, which is responsible for producing GABA, and laboratory testing confirmed it produces GABA at a level of 0.96 grams per liter. This production level is meaningful because it suggests the bacteria could be effective in functional food applications. The genome also contains multiple genes that support probiotic functions, including the ability to survive in acidic stomach environments, tolerate bile salts from the liver, stick to intestinal walls, and handle temperature stress from heat and cold.
Beyond GABA production, the bacteria’s genome revealed several additional beneficial features. The strain contains genes for producing antioxidants, which help reduce cellular damage, and genes that may support immune system function. The genome also carries genetic instructions for producing plantaricins and other antimicrobial compounds that could help fight harmful bacteria in the gut. Additionally, the bacteria contains genes for producing secondary metabolites, which are compounds that may have additional health benefits. Importantly, safety analysis found no major virulence factors (genes that cause disease) and no antibiotic resistance genes, suggesting the bacteria is non-pathogenic and safe.
GABA-producing lactic acid bacteria have been studied before, but most research focuses on land-based strains. Marine-derived strains like this one are less well understood and represent a new frontier in probiotic research. This particular strain appears to have advantages over some previously studied bacteria because it combines high GABA production with multiple probiotic genes and a clean safety profile. The research builds on growing interest in psychobiotics, which are probiotics designed to influence the gut-brain connection through the microbiota-gut-brain axis, a communication system between digestive bacteria and the brain.
This study analyzed bacterial genetics in a laboratory setting only, not in living organisms or humans. The GABA production was measured under specific laboratory conditions that may not reflect real-world conditions in the human gut. No human studies have been conducted, so we cannot confirm that consuming this bacteria would actually increase GABA levels in the brain or improve mental health. The study did not test whether the bacteria survives the journey through the stomach or successfully colonizes the intestines. Additionally, the sample size is one bacterial strain, so results cannot be generalized to other bacteria species.
The Bottom Line
This research provides promising preliminary evidence that Lactiplantibacillus plantarum EI6 could be developed into a safe probiotic supplement. However, human clinical trials are necessary before making any health claims or recommendations. Confidence level: Low to moderate for potential benefits, high for safety based on genetic analysis. Anyone interested in this bacteria as a future supplement should wait for human studies before expecting specific health improvements.
This research is most relevant to people interested in psychobiotics, gut-brain health, and mental wellness through nutrition. Researchers and supplement companies developing new probiotic products should find this work valuable. People with anxiety, depression, or digestive issues may eventually benefit if human studies confirm effectiveness. However, this is not yet ready for consumer use. People with compromised immune systems should consult healthcare providers before using any new probiotics.
This is early-stage research, so realistic expectations are important. The bacteria has been genetically characterized and shown to produce GABA in the lab, but human studies would typically take 2 to 5 years to complete. Even if human trials show benefits, regulatory approval and commercialization could take several additional years. Do not expect this specific strain to be available as a consumer product in the immediate future.
Frequently Asked Questions
What is GABA and why does it matter for brain health?
GABA is a chemical messenger in the brain that helps calm nerve activity and reduce anxiety. Low GABA levels are associated with anxiety and stress. This bacteria produces GABA at 0.96 grams per liter, potentially offering a natural way to support brain health through probiotics.
Is this marine bacteria safe to consume?
Genetic analysis found no virulence factors or antibiotic resistance genes, suggesting it is non-pathogenic and safe. However, human safety studies have not been conducted yet. Comprehensive clinical trials would be needed before it becomes available as a consumer product.
How does the gut-brain axis work with probiotics?
The gut-brain axis is a communication system between digestive bacteria and the brain. Probiotics that produce GABA or other neuroactive compounds may influence this system, potentially affecting mood, anxiety, and stress levels through the vagus nerve and other pathways.
When will this probiotic be available as a supplement?
This is early-stage research. Human clinical trials would typically take 2 to 5 years, followed by regulatory approval and commercialization. This specific strain is not yet available for consumer use and remains a research candidate.
How is this bacteria different from other probiotics?
Most studied probiotics are land-based strains. This marine-derived bacteria combines high GABA production with multiple probiotic genes and a clean safety profile, making it a promising psychobiotic candidate for supporting both gut and brain health.
Want to Apply This Research?
- Users could track mood, anxiety levels, and digestive health on a daily scale (1-10) if they eventually use this probiotic in a clinical trial or approved product. Record sleep quality, energy levels, and any digestive changes weekly to monitor potential gut-brain benefits over time.
- Once this bacteria becomes available through clinical trials or approved products, users could set a daily reminder to take the supplement at the same time each day. Pair the habit with an existing routine like breakfast or bedtime to ensure consistent use and track adherence in the app.
- Implement a long-term tracking dashboard showing mood trends, digestive symptoms, and stress levels over weeks and months. Compare baseline measurements before starting the probiotic to measurements after 4, 8, and 12 weeks of use to identify patterns and potential benefits.
This research describes laboratory analysis of bacterial genetics and GABA production in controlled conditions. No human studies have been conducted with this strain. These findings are preliminary and do not constitute medical advice or health claims. This bacteria is not currently available as a consumer product. Anyone considering probiotic supplements should consult with a healthcare provider, especially those with compromised immune systems, serious health conditions, or taking medications. Do not use this information to self-diagnose or self-treat any health condition. Future human clinical trials are necessary to confirm any health benefits suggested by this genomic analysis.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.